Literature DB >> 25443425

Metabolic remodelling in obesity and type 2 diabetes: pathological or protective mechanisms in response to nutrient excess?

Timothy Connor1, Sheree D Martin, Kirsten F Howlett, Sean L McGee.   

Abstract

Altered metabolism in tissues such as the liver, skeletal muscle and adipose tissue is observed in metabolic diseases characterized by nutrient excess and energy imbalance, such as obesity and type 2 diabetes. These alterations in metabolism can include resistance to the hormone insulin, lipid accumulation, mitochondrial dysfunction and transcriptional remodelling of major metabolic pathways. The underlying assumption has been that these same alterations in metabolism are fundamental to the pathogenesis of metabolic diseases. An alternative view is that these alterations in metabolism occur to protect cell and tissue viability in the face of constant positive energy balance. This speculative review presents evidence that many of the metabolic adaptations that occur in metabolic diseases characterized by nutrient excess can be viewed as protective in nature, rather than pathogenic per se for disease progression. Finally, we also briefly discuss the usefulness and potential pitfalls of therapeutic approaches that attempt to correct these same metabolic defects when energy balance is not altered, and the potential links between metabolic survival responses and other chronic diseases such as cancer.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  cell survival; gene expression; heart; insulin resistance; liver; mitochondria; muscle

Mesh:

Year:  2015        PMID: 25443425     DOI: 10.1111/1440-1681.12315

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

Review 1.  The regulatory roles of O-GlcNAcylation in mitochondrial homeostasis and metabolic syndrome.

Authors:  Lin Zhao; Zhihui Feng; Xiaoyong Yang; Jiankang Liu
Journal:  Free Radic Res       Date:  2016-10-19

2.  The role of mitochondrial DNA damage at skeletal muscle oxidative stress on the development of type 2 diabetes.

Authors:  Julia Matzenbacher Dos Santos; Denise Silva de Oliveira; Marcos Lazaro Moreli; Sandra Aparecida Benite-Ribeiro
Journal:  Mol Cell Biochem       Date:  2018-04-20       Impact factor: 3.396

3.  Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality.

Authors:  Carlos E Mendez; Rebekah J Walker; Christian R Eiler; Basem M Mishriky; Leonard E Egede
Journal:  Postgrad Med       Date:  2019-07-23       Impact factor: 3.840

Review 4.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

5.  The sedentary (r)evolution: Have we lost our metabolic flexibility?

Authors:  Jens Freese; Rainer Johannes Klement; Begoña Ruiz-Núñez; Sebastian Schwarz; Helmut Lötzerich
Journal:  F1000Res       Date:  2017-10-02

6.  Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.

Authors:  Christophe Beauloye; Anne-Catherine Pouleur; Sibille Lejeune; Clotilde Roy; Alisson Slimani; Agnès Pasquet; David Vancraeynest; Jean-Louis Vanoverschelde; Bernhard L Gerber
Journal:  Cardiovasc Diabetol       Date:  2021-02-19       Impact factor: 9.951

Review 7.  TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

Authors:  Christopher R Shepard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

8.  Acute exposure to environmentally relevant levels of DDT alters muscle mitochondrial function in vivo in rats but not in vitro in L6 myotubes: A pilot study.

Authors:  Lucia Chehade; Hannah Khouri; Julie Malatier-Ségard; Audrey Caron; Jean-François Mauger; Natalie Ann Chapados; Céline Aguer
Journal:  Toxicol Rep       Date:  2022-03-05

9.  Fasting-induced liver GADD45β restrains hepatic fatty acid uptake and improves metabolic health.

Authors:  Jessica Fuhrmeister; Annika Zota; Tjeerd P Sijmonsma; Oksana Seibert; Şahika Cıngır; Kathrin Schmidt; Nicola Vallon; Roldan M de Guia; Katharina Niopek; Mauricio Berriel Diaz; Adriano Maida; Matthias Blüher; Jürgen G Okun; Stephan Herzig; Adam J Rose
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.